Related Experiment Videos
Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in
I Kligman1, N Noyes, C A Benadiva
1Department of Obstetrics and Gynecology, Cornell University Medical College, New York, New York.
Objective:
To present the first report of a thromboembolic complication in early pregnancy after ovarian hyperstimulation for IVF in a patient with AT III deficiency who was treated successfully and subsequently delivered a healthy male infant at 32 weeks of gestation.
Design:
Case report.
Setting:
Hospital-based clinic for reproductive medicine.
Patient:
A 28-year-old woman who consulted our IVF clinic with a 3.5-year history of primary infertility.
Interventions:
Intravenous heparin therapy.
Results:
The patient responded adequately to heparin therapy and was discharged home on SC heparin. A primary cesarean section was performed at 32 weeks of gestation because of poor fetal growth and transverse lie.
Conclusions:
We stress the importance of obtaining a thorough personal and family history before initiation of ovarian hyperstimulation. Measuring activity of AT III, protein C, and protein S in patients with a suspicious history of thromboembolic episodes occurring at an early age may lead to the implementation of appropriate prophylactic measures, preventing potentially life-threatening complications.